Most cited papers from Mylan (United Kingdom)

Mylan (United Kingdom)

What are the most cited papers from Mylan (United Kingdom)?

The most cited paper from Mylan (United Kingdom) is "Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs)" (Trevor Riley, David Christopher, Jan Arp et al., 2012), with 104 citations. Next come "Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs" (74) and "Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs" (34).

Published TypeFieldAccess

Showing 17 of 17 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs) Trevor Riley, David Christopher, Jan Arp et al. · AAPS PharmSciTech Open access	14 Jul 2012	104
2	Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs Per Bäckman, Sumit Arora, William R. Couet et al. · European Journal of Pharmaceutical Sciences Open access	25 Oct 2017	74
3	Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs Carsten Ehrhardt, Per Bäckman, William R. Couet et al. · Journal of Pharmaceutical Sciences Open access	15 Apr 2017	34
4	A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim Cornelius F. Waller, Renger G. Tiessen, Tracey E. Lawrence et al. · Journal of Cancer Research and Clinical Oncology Open access	18 Apr 2018	31
5	A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL‐1401O vs. EU‐trastuzumab and US‐trastuzumab Cornelius Florian Waller, Apinya Vutikullird, Tracey E. Lawrence et al. · British Journal of Clinical Pharmacology Open access	21 Jun 2018	30
6	Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia Cornelius Florian Waller, Gopinath M. Ranganna, Eduardo J. Pennella et al. · Annals of Hematology Open access	Mar 2019	26
7	The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device Donald P. Tashkin, Jill A. Ohar, Arkady Koltun et al. · Pulmonary Medicine Open access	17 Mar 2021	19
8	Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different Devices Johanna Melin, Susanne Prothon, Charlotte Kloft et al. · The AAPS Journal	9 Mar 2017	15
9	Particle size and gastrointestinal absorption influence tiotropium pharmacokinetics: a pilot bioequivalence study of PUR0200 and Spiriva HandiHaler Jason K. Perry, Brian G. Trautman, Joe Takher‐Smith et al. · British Journal of Clinical Pharmacology Open access	6 Dec 2018	9
10	Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD Nicola Alexander Hanania, Sanjay Sethi, Arkady Koltun et al. · International Journal of COPD Open access	Dec 2018	8
11	Medicines for older people: assessment and transparency at the European Medicines Agency regarding cardiovascular and antithrombotic medicinal products Francesca Cerreta, Andreia Padrão, Izabela Skibicka-Stepien et al. · European Geriatric Medicine	14 Jun 2018	8
12	Performance of the Population Bioequivalence (PBE) Statistical Test Using an IPAC-RS Database of Delivered Dose from Metered Dose Inhalers Beth Morgan, Stephanie Y Chen, David Christopher et al. · AAPS PharmSciTech	12 Feb 2018	5
13	Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-neulasta® in the prophylaxis of chemotherapy-induced neutropenia Cornelius Florian Waller, Christopher Blakeley, Eduardo J. Pennella et al. · Annals of Oncology Open access	Oct 2016	5
14	Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD James F. Donohue, Douglas S Burgoyne, Jonathan K. Ward et al. · Pulmonary Therapy Open access	7 Dec 2020	4
15	Validating AIM-Based Instrumentation and Associated Measurement Techniques Mark Copley, Jolyon P. Mitchell, Mårten Svensson et al. Book chapter	2013	4
16	Lung deposition of inhaled once-daily long-acting muscarinic antagonists via standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients with chronic obstructive pulmonary disease Glenn Crater, Karmon Johnson, Jonathan K. Ward et al. · Therapeutic Advances in Respiratory Disease Open access	2022	3
17	A pharmacokinetics and pharmacodynamics equivalence trial of proposed pegfilgrastim biosimilar, MYL-1401H vs EU neulasta® and US neulasta® Cornelius Florian Waller, Renger G. Tiessen, Tracey E. Lawrence et al. · Annals of Oncology Open access	Oct 2016	3

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.